Cargando…
Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience
OBJECTIVE: Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been used with variable results. Therefore, we aimed to evaluate the effects of zoledronic acid (ZA) t...
Autores principales: | Valadares, Luciana Pinto, Ferreira, Bruno Silva de Araújo, da Cunha, Bernardo Matos, Moreira, Larissa Aniceto, Batista, Frederico Gideoni Albinati, Hottz, Cristiane da Fonseca, Magalhães, Gabriel Galvão Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832888/ https://www.ncbi.nlm.nih.gov/pubmed/35420267 http://dx.doi.org/10.20945/2359-3997000000459 |
Ejemplares similares
-
Factors Associated With Inadequate Response to Bisphosphonate Therapy in Patients With Osteoporosis in Real-Life Clinical Practice: a Single-Center Retrospective Analysis of 300 Patients
por: Valadares, Luciana Pinto, et al.
Publicado: (2021) -
Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
por: Ferreira, Bruno S. A., et al.
Publicado: (2021) -
Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
por: Di Pede, Chiara, et al.
Publicado: (2016) -
Response to Zoledronic Acid Infusion in Children With Fibrous Dysplasia
por: Tripathy, Sujit Kumar, et al.
Publicado: (2020) -
Intralesional zoledronate: A novel therapy to treat fibrous dysplasia
por: Gopinathan, Nirmal Raj, et al.
Publicado: (2020)